Disseminated Mycobacterium kansasii and Mycobacterium avium complex co-infection in GATA2 mutated myelodysplastic syndrome: a case report Article Swipe
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1177/20499361251359825
A 79-year-old female diagnosed with myelodysplastic syndrome (MDS) and germline GATA2 mutation, on compassionate cobimetinib, was admitted with subacute cough and dyspnea. Chest imaging demonstrated a new, large, left hilar mass and consolidation with scattered diffuse mediastinal, supraclavicular, and hilar lymphadenopathy. A core biopsy of the right supraclavicular lymph node was performed. Acid-fast bacilli (AFB) cultures from both the lymph node and blood were positive, while all fungal cultures were negative. Two distinct AFB colonies were observed on solid media and identified as Mycobacterium avium complex and Mycobacterium kansasii. Disseminated non-tuberculous mycobacterial infections involving two distinct species are rare, pose treatment challenges, and may correlate with cobimetinib administration for MDS, as well as GATA2 germline mutations.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1177/20499361251359825
- OA Status
- gold
- References
- 17
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4413894320
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4413894320Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1177/20499361251359825Digital Object Identifier
- Title
-
Disseminated Mycobacterium kansasii and Mycobacterium avium complex co-infection in GATA2 mutated myelodysplastic syndrome: a case reportWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-07-01Full publication date if available
- Authors
-
Sabrina E Newstead, Daniel Montelongo, Salika M. Shakir, Neeraja SwaminathanList of authors in order
- Landing page
-
https://doi.org/10.1177/20499361251359825Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1177/20499361251359825Direct OA link when available
- Concepts
-
Mycobacterium kansasii, Nontuberculous mycobacteria, Medicine, Mycobacterium, Mediastinal lymphadenopathy, Mycobacterium tuberculosis, Germline, Lymph node, Pathology, Biopsy, Tuberculosis, Biology, Biochemistry, GeneTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
17Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4413894320 |
|---|---|
| doi | https://doi.org/10.1177/20499361251359825 |
| ids.doi | https://doi.org/10.1177/20499361251359825 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40904814 |
| ids.openalex | https://openalex.org/W4413894320 |
| fwci | 0.0 |
| type | article |
| title | Disseminated Mycobacterium kansasii and Mycobacterium avium complex co-infection in GATA2 mutated myelodysplastic syndrome: a case report |
| biblio.issue | |
| biblio.volume | 12 |
| biblio.last_page | 20499361251359825 |
| biblio.first_page | 20499361251359825 |
| topics[0].id | https://openalex.org/T11316 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2713 |
| topics[0].subfield.display_name | Epidemiology |
| topics[0].display_name | Mycobacterium research and diagnosis |
| topics[1].id | https://openalex.org/T10038 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9983999729156494 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2725 |
| topics[1].subfield.display_name | Infectious Diseases |
| topics[1].display_name | Tuberculosis Research and Epidemiology |
| topics[2].id | https://openalex.org/T12317 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9980000257492065 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2726 |
| topics[2].subfield.display_name | Microbiology |
| topics[2].display_name | Actinomycetales infections and treatment |
| is_xpac | False |
| apc_list.value | 1500 |
| apc_list.currency | USD |
| apc_list.value_usd | 1500 |
| apc_paid.value | 1500 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 1500 |
| concepts[0].id | https://openalex.org/C2780931024 |
| concepts[0].level | 4 |
| concepts[0].score | 0.9131879806518555 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q4044720 |
| concepts[0].display_name | Mycobacterium kansasii |
| concepts[1].id | https://openalex.org/C2778679867 |
| concepts[1].level | 4 |
| concepts[1].score | 0.6334383487701416 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1881705 |
| concepts[1].display_name | Nontuberculous mycobacteria |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.6136370301246643 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C2780374374 |
| concepts[3].level | 3 |
| concepts[3].score | 0.5270766615867615 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q194309 |
| concepts[3].display_name | Mycobacterium |
| concepts[4].id | https://openalex.org/C2776313322 |
| concepts[4].level | 3 |
| concepts[4].score | 0.47702905535697937 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q6806164 |
| concepts[4].display_name | Mediastinal lymphadenopathy |
| concepts[5].id | https://openalex.org/C2777975735 |
| concepts[5].level | 3 |
| concepts[5].score | 0.4457799792289734 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q130971 |
| concepts[5].display_name | Mycobacterium tuberculosis |
| concepts[6].id | https://openalex.org/C109825262 |
| concepts[6].level | 3 |
| concepts[6].score | 0.440122127532959 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1139164 |
| concepts[6].display_name | Germline |
| concepts[7].id | https://openalex.org/C2780849966 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4213974177837372 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q170758 |
| concepts[7].display_name | Lymph node |
| concepts[8].id | https://openalex.org/C142724271 |
| concepts[8].level | 1 |
| concepts[8].score | 0.37340667843818665 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[8].display_name | Pathology |
| concepts[9].id | https://openalex.org/C2775934546 |
| concepts[9].level | 2 |
| concepts[9].score | 0.37212321162223816 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q179991 |
| concepts[9].display_name | Biopsy |
| concepts[10].id | https://openalex.org/C2781069245 |
| concepts[10].level | 2 |
| concepts[10].score | 0.36450403928756714 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q12204 |
| concepts[10].display_name | Tuberculosis |
| concepts[11].id | https://openalex.org/C86803240 |
| concepts[11].level | 0 |
| concepts[11].score | 0.21300876140594482 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[11].display_name | Biology |
| concepts[12].id | https://openalex.org/C55493867 |
| concepts[12].level | 1 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[12].display_name | Biochemistry |
| concepts[13].id | https://openalex.org/C104317684 |
| concepts[13].level | 2 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[13].display_name | Gene |
| keywords[0].id | https://openalex.org/keywords/mycobacterium-kansasii |
| keywords[0].score | 0.9131879806518555 |
| keywords[0].display_name | Mycobacterium kansasii |
| keywords[1].id | https://openalex.org/keywords/nontuberculous-mycobacteria |
| keywords[1].score | 0.6334383487701416 |
| keywords[1].display_name | Nontuberculous mycobacteria |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.6136370301246643 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/mycobacterium |
| keywords[3].score | 0.5270766615867615 |
| keywords[3].display_name | Mycobacterium |
| keywords[4].id | https://openalex.org/keywords/mediastinal-lymphadenopathy |
| keywords[4].score | 0.47702905535697937 |
| keywords[4].display_name | Mediastinal lymphadenopathy |
| keywords[5].id | https://openalex.org/keywords/mycobacterium-tuberculosis |
| keywords[5].score | 0.4457799792289734 |
| keywords[5].display_name | Mycobacterium tuberculosis |
| keywords[6].id | https://openalex.org/keywords/germline |
| keywords[6].score | 0.440122127532959 |
| keywords[6].display_name | Germline |
| keywords[7].id | https://openalex.org/keywords/lymph-node |
| keywords[7].score | 0.4213974177837372 |
| keywords[7].display_name | Lymph node |
| keywords[8].id | https://openalex.org/keywords/pathology |
| keywords[8].score | 0.37340667843818665 |
| keywords[8].display_name | Pathology |
| keywords[9].id | https://openalex.org/keywords/biopsy |
| keywords[9].score | 0.37212321162223816 |
| keywords[9].display_name | Biopsy |
| keywords[10].id | https://openalex.org/keywords/tuberculosis |
| keywords[10].score | 0.36450403928756714 |
| keywords[10].display_name | Tuberculosis |
| keywords[11].id | https://openalex.org/keywords/biology |
| keywords[11].score | 0.21300876140594482 |
| keywords[11].display_name | Biology |
| language | en |
| locations[0].id | doi:10.1177/20499361251359825 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210217046 |
| locations[0].source.issn | 2049-9361, 2049-937X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2049-9361 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Therapeutic Advances in Infectious Disease |
| locations[0].source.host_organization | https://openalex.org/P4310320017 |
| locations[0].source.host_organization_name | SAGE Publishing |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320017 |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Therapeutic Advances in Infectious Disease |
| locations[0].landing_page_url | https://doi.org/10.1177/20499361251359825 |
| locations[1].id | pmid:40904814 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Therapeutic advances in infectious disease |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40904814 |
| locations[2].id | pmh:oai:doaj.org/article:c6bd0a316eb24ec8b43dc97e97007956 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].source.host_organization_lineage | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Therapeutic Advances in Infectious Disease, Vol 12 (2025) |
| locations[2].landing_page_url | https://doaj.org/article/c6bd0a316eb24ec8b43dc97e97007956 |
| locations[3].id | pmh:oai:europepmc.org:11212630 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306400806 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | Europe PMC (PubMed Central) |
| locations[3].source.host_organization | https://openalex.org/I1303153112 |
| locations[3].source.host_organization_name | European Bioinformatics Institute |
| locations[3].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12402566 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5116075839 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Sabrina E Newstead |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I2803026726 |
| authorships[0].affiliations[0].raw_affiliation_string | University of Utah Hospital, 30 N 1900 E #4B319, Salt Lake City, UT 84132, USA |
| authorships[0].institutions[0].id | https://openalex.org/I2803026726 |
| authorships[0].institutions[0].ror | https://ror.org/03b436430 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I2803026726 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | University of Utah Hospital |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Sabrina Newstead |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | University of Utah Hospital, 30 N 1900 E #4B319, Salt Lake City, UT 84132, USA |
| authorships[1].author.id | https://openalex.org/A5119504211 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Daniel Montelongo |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I867280407 |
| authorships[1].affiliations[0].raw_affiliation_string | The University of Texas Southwestern Medical Center, Dallas, TX, USA |
| authorships[1].institutions[0].id | https://openalex.org/I867280407 |
| authorships[1].institutions[0].ror | https://ror.org/05byvp690 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I867280407 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | The University of Texas Southwestern Medical Center |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Daniel Montelongo |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | The University of Texas Southwestern Medical Center, Dallas, TX, USA |
| authorships[2].author.id | https://openalex.org/A5049730998 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-4642-8574 |
| authorships[2].author.display_name | Salika M. Shakir |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I2803026726, https://openalex.org/I61474668 |
| authorships[2].affiliations[0].raw_affiliation_string | ARUP Laboratories, University of Utah Hospital, Salt Lake City, UT, USA |
| authorships[2].institutions[0].id | https://openalex.org/I61474668 |
| authorships[2].institutions[0].ror | https://ror.org/00c2tyx86 |
| authorships[2].institutions[0].type | company |
| authorships[2].institutions[0].lineage | https://openalex.org/I61474668 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | ARUP Laboratories (United States) |
| authorships[2].institutions[1].id | https://openalex.org/I2803026726 |
| authorships[2].institutions[1].ror | https://ror.org/03b436430 |
| authorships[2].institutions[1].type | healthcare |
| authorships[2].institutions[1].lineage | https://openalex.org/I2803026726 |
| authorships[2].institutions[1].country_code | US |
| authorships[2].institutions[1].display_name | University of Utah Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Salika Shakir |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | ARUP Laboratories, University of Utah Hospital, Salt Lake City, UT, USA |
| authorships[3].author.id | https://openalex.org/A5002204000 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-9043-0420 |
| authorships[3].author.display_name | Neeraja Swaminathan |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I2803026726 |
| authorships[3].affiliations[0].raw_affiliation_string | University of Utah Hospital, Salt Lake City, UT, USA |
| authorships[3].institutions[0].id | https://openalex.org/I2803026726 |
| authorships[3].institutions[0].ror | https://ror.org/03b436430 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I2803026726 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | University of Utah Hospital |
| authorships[3].author_position | last |
| authorships[3].raw_author_name | Neeraja Swaminathan |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | University of Utah Hospital, Salt Lake City, UT, USA |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1177/20499361251359825 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Disseminated Mycobacterium kansasii and Mycobacterium avium complex co-infection in GATA2 mutated myelodysplastic syndrome: a case report |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11316 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2713 |
| primary_topic.subfield.display_name | Epidemiology |
| primary_topic.display_name | Mycobacterium research and diagnosis |
| related_works | https://openalex.org/W2588998366, https://openalex.org/W2906042782, https://openalex.org/W2565102560, https://openalex.org/W2302301794, https://openalex.org/W2412998288, https://openalex.org/W2179681267, https://openalex.org/W4253738305, https://openalex.org/W2013109239, https://openalex.org/W1590319477, https://openalex.org/W4254394760 |
| cited_by_count | 0 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1177/20499361251359825 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210217046 |
| best_oa_location.source.issn | 2049-9361, 2049-937X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2049-9361 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Therapeutic Advances in Infectious Disease |
| best_oa_location.source.host_organization | https://openalex.org/P4310320017 |
| best_oa_location.source.host_organization_name | SAGE Publishing |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320017 |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Therapeutic Advances in Infectious Disease |
| best_oa_location.landing_page_url | https://doi.org/10.1177/20499361251359825 |
| primary_location.id | doi:10.1177/20499361251359825 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210217046 |
| primary_location.source.issn | 2049-9361, 2049-937X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2049-9361 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Therapeutic Advances in Infectious Disease |
| primary_location.source.host_organization | https://openalex.org/P4310320017 |
| primary_location.source.host_organization_name | SAGE Publishing |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320017 |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Therapeutic Advances in Infectious Disease |
| primary_location.landing_page_url | https://doi.org/10.1177/20499361251359825 |
| publication_date | 2025-07-01 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W2995199373, https://openalex.org/W3009543471, https://openalex.org/W4385660338, https://openalex.org/W4365453852, https://openalex.org/W4281685550, https://openalex.org/W3159915441, https://openalex.org/W4307747972, https://openalex.org/W4392244707, https://openalex.org/W4310785649, https://openalex.org/W4310602582, https://openalex.org/W4283658163, https://openalex.org/W3147301079, https://openalex.org/W2313770505, https://openalex.org/W4407001133, https://openalex.org/W2911798461, https://openalex.org/W2111172126, https://openalex.org/W2142447693 |
| referenced_works_count | 17 |
| abstract_inverted_index.A | 0, 41 |
| abstract_inverted_index.a | 25 |
| abstract_inverted_index.as | 82, 110, 112 |
| abstract_inverted_index.of | 44 |
| abstract_inverted_index.on | 12, 77 |
| abstract_inverted_index.AFB | 73 |
| abstract_inverted_index.Two | 71 |
| abstract_inverted_index.all | 66 |
| abstract_inverted_index.and | 8, 20, 31, 38, 61, 80, 86, 102 |
| abstract_inverted_index.are | 97 |
| abstract_inverted_index.for | 108 |
| abstract_inverted_index.may | 103 |
| abstract_inverted_index.the | 45, 58 |
| abstract_inverted_index.two | 94 |
| abstract_inverted_index.was | 15, 50 |
| abstract_inverted_index.MDS, | 109 |
| abstract_inverted_index.both | 57 |
| abstract_inverted_index.core | 42 |
| abstract_inverted_index.from | 56 |
| abstract_inverted_index.left | 28 |
| abstract_inverted_index.mass | 30 |
| abstract_inverted_index.new, | 26 |
| abstract_inverted_index.node | 49, 60 |
| abstract_inverted_index.pose | 99 |
| abstract_inverted_index.well | 111 |
| abstract_inverted_index.were | 63, 69, 75 |
| abstract_inverted_index.with | 4, 17, 33, 105 |
| abstract_inverted_index.(AFB) | 54 |
| abstract_inverted_index.(MDS) | 7 |
| abstract_inverted_index.Chest | 22 |
| abstract_inverted_index.GATA2 | 10, 113 |
| abstract_inverted_index.avium | 84 |
| abstract_inverted_index.blood | 62 |
| abstract_inverted_index.cough | 19 |
| abstract_inverted_index.hilar | 29, 39 |
| abstract_inverted_index.lymph | 48, 59 |
| abstract_inverted_index.media | 79 |
| abstract_inverted_index.rare, | 98 |
| abstract_inverted_index.right | 46 |
| abstract_inverted_index.solid | 78 |
| abstract_inverted_index.while | 65 |
| abstract_inverted_index.biopsy | 43 |
| abstract_inverted_index.female | 2 |
| abstract_inverted_index.fungal | 67 |
| abstract_inverted_index.large, | 27 |
| abstract_inverted_index.bacilli | 53 |
| abstract_inverted_index.complex | 85 |
| abstract_inverted_index.diffuse | 35 |
| abstract_inverted_index.imaging | 23 |
| abstract_inverted_index.species | 96 |
| abstract_inverted_index.admitted | 16 |
| abstract_inverted_index.colonies | 74 |
| abstract_inverted_index.cultures | 55, 68 |
| abstract_inverted_index.distinct | 72, 95 |
| abstract_inverted_index.dyspnea. | 21 |
| abstract_inverted_index.germline | 9, 114 |
| abstract_inverted_index.observed | 76 |
| abstract_inverted_index.subacute | 18 |
| abstract_inverted_index.syndrome | 6 |
| abstract_inverted_index.Acid-fast | 52 |
| abstract_inverted_index.correlate | 104 |
| abstract_inverted_index.diagnosed | 3 |
| abstract_inverted_index.involving | 93 |
| abstract_inverted_index.kansasii. | 88 |
| abstract_inverted_index.mutation, | 11 |
| abstract_inverted_index.negative. | 70 |
| abstract_inverted_index.positive, | 64 |
| abstract_inverted_index.scattered | 34 |
| abstract_inverted_index.treatment | 100 |
| abstract_inverted_index.identified | 81 |
| abstract_inverted_index.infections | 92 |
| abstract_inverted_index.mutations. | 115 |
| abstract_inverted_index.performed. | 51 |
| abstract_inverted_index.79-year-old | 1 |
| abstract_inverted_index.challenges, | 101 |
| abstract_inverted_index.cobimetinib | 106 |
| abstract_inverted_index.Disseminated | 89 |
| abstract_inverted_index.cobimetinib, | 14 |
| abstract_inverted_index.demonstrated | 24 |
| abstract_inverted_index.mediastinal, | 36 |
| abstract_inverted_index.Mycobacterium | 83, 87 |
| abstract_inverted_index.compassionate | 13 |
| abstract_inverted_index.consolidation | 32 |
| abstract_inverted_index.mycobacterial | 91 |
| abstract_inverted_index.administration | 107 |
| abstract_inverted_index.myelodysplastic | 5 |
| abstract_inverted_index.non-tuberculous | 90 |
| abstract_inverted_index.supraclavicular | 47 |
| abstract_inverted_index.lymphadenopathy. | 40 |
| abstract_inverted_index.supraclavicular, | 37 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 4 |
| citation_normalized_percentile.value | 0.5053706 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |